ruboxistaurin (LY333531)

ruboxistaurin · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ruboxistaurin (LY333531), covering 2016-07-26 to 2016-07-26. Get the full timeline:

Most recent: Clinical Trial Update: Effect of LY333531 on Vascular and Neural Functions [Phase 2]